Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02052167 · ClinicalTrials.gov registry record · Early Phase 1
Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis
A Early Phase 1 study, sponsored by medac.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT02052167 is a Early Phase 1 study that has completed, run by medac. The registered enrollment target is 30 participants.
The verdict
NCT02052167, a Early Phase 1 study, has completed, sponsored by medac.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is planned to evaluate the human factor (HF)/usability of pediatric or adolescent JIA patients and the caregivers of Juvenile Idiopathic Arthritis (JIA) patients with the Methotrexate Prefilled Pen (including a label comprehension assessment and a device robustness evaluation).
Interventions
- DEVICE methotrexate prefilled pen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02052167
The ClinicalTrials.gov registry entry for NCT02052167 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is medac, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which methotrexate prefilled pen is the first listed.
NCT02052167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02052167 about?
NCT02052167 is a clinical study titled "Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis". This study is planned to evaluate the human factor (HF)/usability of pediatric or adolescent JIA patients and the caregivers of Juvenile Idiopathic Arthritis (JIA) patients with the Methotrexate Prefilled Pen (including a label comprehension assessment and a device robustness evaluation).
What is the current status of trial NCT02052167?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2014-04. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02052167?
The interventions under investigation include: methotrexate prefilled pen (DEVICE).
Who is sponsoring clinical trial NCT02052167?
This trial is sponsored by medac, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.